Active substanceLaminaria thallusLaminaria thallus
Similar drugsTo uncover
  • Laminaria thallus (Sea kale)
    raw materials. inwards 
    LEK S +, LLC     Russia
  • Laminaria thallus - sea kale
    raw materials. inwards 
  • Laminaria thallus - sea kale
    raw materials. inwards 
  • Laminaria thallus - sea kale
    raw materials. inwards 
    St.-MEDIFARM, CJSC     Russia
  • Laminaria thallus - sea kale
    raw materials. inwards 
    FITOFARM PKF, LLC     Russia
  • Laminaria thick extract
    raw materials.extract inwards 
    GIPPOKRAT, LLC     Russia
  • Mamoclam®
    pills inwards 
  • PhytoTranzym®
    pills inwards 
    EVALAR, CJSC     Russia
  • Dosage form: & nbsppills
    Composition:

    Composition per one tablet

    Active ingredient: Laminaria thallus - 0,49 g.

    Excipients: silicon dioxide colloid - 0.0075 g, calcium stearate - 0.0025 g.

    Description:

    Tablets are round cylindrical with a biconvex surface. The surface is slightly rough, a layered structure is visible on the fault and on the side. Color of tablets from greenish-gray to greenish-brown with yellowish, greenish-yellow, greenish-brown, black, rarely reddish-brown impregnations. The smell is weak, peculiar.

    Pharmacotherapeutic group:Laxative herbal remedy
    ATX: & nbsp

    A.06.A.X   Other laxatives

    Pharmacodynamics:

    Has a laxative, thyroid and hypolipidemic action.

    Laxative effect is due to the ability of the drug to swell and, increasing in volume, cause irritation of receptors of the intestinal mucosa.

    Indications:Chronic atonic constipation, including in patients with hyperlipidemia.
    Contraindications:

    Increased individual sensitivity (including iodine), hyperthyroidism, multinodular goitre, thyrotoxicosis of various genesis, nephritis, nephrosis, hemorrhagic diathesis, furunculosis, acne, chronic pyoderma, intestinal obstruction, acute abdominal syndrome, inflammatory diseases of the abdominal cavity (in including appendicitis), acute febrile conditions, children under 18 years of age.

    Pregnancy and lactation:

    The drug should not be used during pregnancy and during breastfeeding.

    Dosing and Administration:

    Apply inside 6-12 tablets 1 time per day. Tablets are swallowed or chewed with a sufficient amount of water.

    The course of treatment is 15-30 days.

    Side effects:

    With long-term use and increased sensitivity to iodine, the phenomena of iodism are possible (runny nose, urticaria, Quincke's edema, salivation, lacrimation, acne, etc.), allergic reactions (skin itching, skin hyperemia).

    Overdose:

    To date, cases of overdose with the use of the drug Fito-Transit® is not registered.

    Interaction:

    The interaction of the preparation Phytotransit ® with other medicinal products is not described.

    Form release / dosage:Pills.
    Packaging:

    For 20 tablets in a contour mesh package or 40, 60 or 80 tablets in a can of polymer.

    Each jar or 1, 2, 3 or 4 contour packs together with the instructions for use are placed in a pack of cardboard.

    Storage conditions:

    Store in a dry place protected from light.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N003104 / 01
    Date of registration:15.12.2008
    The owner of the registration certificate:EVALAR, CJSC EVALAR, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp16.09.2015
    Illustrated instructions
      Instructions
      Up